High Tower Advisors, LLC Mannkind Corp Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Mannkind Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 143,393 shares of MNKD stock, worth $873,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares

143,393

Previous 35,833 300.17%

Holding current value

$873,263

Previous $187,000 381.28%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $538,875 - $720,652	107,560 Added 300.17%	143,393 $900,000
Q2 2024 Aug 13, 2024	BUY	$4.05 - $5.43 $3,969 - $5,321	980 Added 2.81%	35,833 $187,000
Q1 2024 May 06, 2024	BUY	$3.25 - $5.27 $5,772 - $9,359	1,776 Added 5.37%	34,853 $157,000
Q3 2023 Nov 08, 2023	BUY	$3.91 - $5.45 $39 - $54	10 Added 0.03%	33,077 $136,000
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $1,302 - $1,676	-350 Reduced 1.05%	33,067 $134,000
Q1 2023 May 11, 2023	BUY	$3.95 - $5.63 $1,777 - $2,533	450 Added 1.37%	33,417 $137,000
Q4 2022 Feb 08, 2023	BUY	$3.02 - $5.37 $2,114 - $3,759	700 Added 2.17%	32,967 $173,000
Q3 2022 Nov 09, 2022	SELL	$2.99 - $4.35 $38,092 - $55,418	-12,740 Reduced 28.31%	32,267 $97,000
Q2 2022 Aug 10, 2022	BUY	$2.67 - $4.77 $34,015 - $60,769	12,740 Added 39.48%	45,007 $171,000
Q1 2022 May 12, 2022	BUY	$2.62 - $4.45 $13,100 - $22,250	5,000 Added 18.34%	32,267 $116,000
Q4 2021 Feb 10, 2022	SELL	$4.05 - $5.37 $101,250 - $134,250	-25,000 Reduced 47.83%	27,267 $119,000
Q3 2021 Nov 12, 2021	BUY	$3.89 - $5.48 $58,139 - $81,904	14,946 Added 40.05%	52,267 $228,000
Q1 2021 May 10, 2021	BUY	$3.14 - $6.14 $72,220 - $141,220	23,000 Added 160.6%	37,321 $145,000
Q4 2020 Feb 10, 2021	BUY	$1.79 - $4.04 $5,835 - $13,170	3,260 Added 29.47%	14,321 $43,000
Q2 2020 Aug 10, 2020	BUY	$0.94 - $2.21 $10,397 - $24,444	11,061 New	11,061 $18,000
Q1 2020 May 21, 2020	SELL	$0.84 - $1.76 $8,695 - $18,219	-10,352 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.14 - $1.49 $1,937 - $2,533	-1,700 Reduced 14.11%	10,352 $12,000
Q3 2019 Nov 12, 2019	BUY	$1.04 - $1.44 $1,038 - $1,438	999 Added 9.04%	12,052 $14,000
Q2 2019 Aug 13, 2019	BUY	$1.09 - $1.88 $12,047 - $20,779	11,053 New	11,053 $12,000

Others Institutions Holding MNKD

# of Institutions

244

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Mannkind Corp Transaction History